Results 111 to 120 of about 185,181 (328)
Patient Preference and Adherence, 2010 Patrick P Kneeland, Margaret C FangThe University of California, San Francisco Division of Hospital Medicine, San Francisco, CA, USAAbstract: Warfarin therapy reduces morbidity and mortality related to thromboembolism. Yet adherence to long-term warfarin
Patrick P Kneeland, Margaret C Fang
doaj
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
New England Journal of Medicine, 2005 BACKGROUND Atherosclerotic intracranial arterial stenosis is an important cause of stroke. Warfarin is commonly used in preference to aspirin for this disorder, but these therapies have not been compared in a randomized trial.
M. Chimowitz +12 more
semanticscholar +1 more source
Drug Testing and Analysis, EarlyView.The new ionization technique, vacuum‐insulated probe‐heated electrospray, allows for a simple dilute‐and‐shoot sample preparation to be used with liquid chromatography time‐of‐flight mass spectrometry in urine drug screening. Comparison with a method relying on solid‐phase extraction and conventional electrospray ionization shows improved performance ...
Mira Sundström +4 more
wiley +1 more source
Simultaneous Effect of Vitamin C and Warfarin on Coagulation Pathways of Rats
Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2009 Introduction: The aim of the present study was to assess variations in coagulating pathways after simultaneous administration of warfarin and vitamin C. Methods: A total of 50 Wistar rats were selected.
S Nazifi, A Khoshvaghti, M Kazemi
doaj
Warfarin Resistance: A Case Report
Eurasian Journal of Emergency Medicine, 2019 Warfarin is the most widely prescribed anticoagulant in the world. Patients who need more than 15 mg per day should be considered warfarin-resistant.
Uğur Gönlügür +3 more
doaj +1 more source
BMC Cardiovascular Disorders, 2019 Background Clinical trials have demonstrated that direct oral anticoagulants (DOACs) are at least non-inferior to warfarin in reducing the risk of stroke/systemic embolism (SE) among patients with non-valvular atrial fibrillation (NVAF), but the ...
Kiran Gupta +7 more
doaj +1 more source
Large-scale structure of brown rat (Rattus norvegicus) populations in England: effects on rodenticide resistance [PDF]
, 2015 The brown rat (Rattus norvegicus) is a relatively recent (
Adams, Sally +6 more
core +2 more sources
ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen +4 more
wiley +1 more source
ОЦЕНКА ТЕРАПЕВТИЧЕСКОЙ ЭФФЕКТИВНОСТИ ВАРФАРИНА ПРОИЗВОДСТВА ЗАО «КАНОНФАРМА ПРАДАКШЕН» (РОССИЯ)
Архивъ внутренней медицины, 2014 Warfarin by «Kanonpharma production» (Russia) and original Warfarin have the similar safety and tolerability. We need some increase of dose of Warfarin by «Kanonpharma production» to reach target rate of INR, then in case of original Warfarin usage.
М. В. Хруслов +1 more
doaj +1 more source
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.
New England Journal of Medicine, 2013 BACKGROUND Dabigatran, which is administered in a fixed dose and does not require laboratory monitoring, may be suitable for extended treatment of venous thromboembolism.
S. Schulman +9 more
semanticscholar +1 more source